Avience Biomedicals (NSE:AVIENCE) General and Admin. Expense: ₹0.0 Mil (TTM As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals General and Admin. Expense?

Avience Biomedicals NSE:AVIENCE 5 General and Admin. Expense is ₹0.0 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Avience Biomedicals's General and Admin. Expense for the three months ended in Jan. 2026 was ₹0.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jan. 2026 was ₹0.0 Mil.

Avience Biomedicals General and Admin. Expense Related Terms

Avience Biomedicals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals General and Admin. Expense Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
General and Admin. Expense
1.75 3.79 3.51

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
General and Admin. Expense 0.00 0.00 0.00 0.00
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of ₹0.0 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a General and Admin. Expense of ₹0.0 Mil as of Jan. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' General and Admin. Expense too high?
Avience Biomedicals' current General and Admin. Expense is ₹0.0 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' General and Admin. Expense compare to ABT and SYK?
Avience Biomedicals' General and Admin. Expense of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Medical Devices & Instruments company?
A good General and Admin. Expense depends on the Medical Devices & Instruments industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current General and Admin. Expense is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current General and Admin. Expense of ₹0.0 Mil. The current General and Admin. Expense is ₹0.0 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current General and Admin. Expense is ₹0.0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price